The burgeoning popularity of tirzepatide , initially for metabolic conditions, is creating significant attention within the British Isles, prompting a notable shift in medication trends. Obtaining these compounds remains a complex challenge , with National Health Service coverage currently limited and independent providers offering therapy at a pre